Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuDHS: Dual HIV and Syphilis PrEP
NCT02844634Phase 4Completed
- Sponsor
- British Columbia Centre for Disease Control
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxycycline in human immunodeficiency virus infection (HIV) and syphilis, sponsored by British Columbia Centre for Disease Control. Primary endpoint: Proportion of participants who are eligible and consent to participate at 12 months. Started May 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
human immunodeficiency virus infection (HIV)syphilis
Beyond the preview
Go deeper on NCT02844634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844634.